New World's old disease: cardiac hydatid disease and surgical principles

Omer Tanyeli1, Yuksel Dereli1, Ilker Mercan1

  • 1Department of Cardiovascular Surgery, Meram Medicine Faculty, Necmettin Erbakan University, Konya, Turkey.

Insights

Cardiac hydatid disease, a rare parasitic infection, can be treated effectively with surgery and medication. Early diagnosis and treatment are crucial, especially in endemic areas, to prevent recurrence.

Area of Science:

  • Parasitology
  • Cardiology
  • Infectious Diseases

Background:

  • Hydatid cyst disease is caused by Echinococcus granulosus larva.
  • It is a significant public health issue in endemic regions.
  • Cardiac involvement is an uncommon manifestation.

Purpose of the Study:

  • To analyze the clinical characteristics, treatment, and outcomes of cardiac hydatid disease.
  • To highlight the importance of considering this rare condition in differential diagnoses.

Main Methods:

  • Retrospective review of 12 patients diagnosed with cardiac hydatid disease between 1985 and 2015.
  • Surgical interventions included median sternotomy and left anterolateral thoracotomy.
  • Medical therapy with mebendazole or albendazole was administered post-surgery.

Main Results:

  • The most frequent cyst location was the left side of the heart (50%).
  • No surgical mortality was observed.
  • All patients received six months of medical therapy with no reported recurrences.

Conclusions:

  • Cardiac hydatid disease, though rare, may be increasing in prevalence.
  • It should be considered in patients with cardiac symptoms suggestive of mass lesions, particularly in developing countries.
  • Surgical cyst removal combined with medical therapy is the definitive treatment.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405